ID | 1609 | |
PMID | 18031459 | |
Year | 2007 | |
Sequence | RKKRRQRRR | |
Name | Tat-PDT | |
Length | 9 | |
N-Terminal Modification | Free | |
C-Terminal Modification | Free | |
Linear/ Cyclic | Linear | |
Chirality | L | |
Chemical Modification | None | |
Origin of Peptide | Synthesized using plasmids | |
Nature of Peptide/Cargo | Not mentioned | |
Mechanism | Not mentioned | |
Cargo Sequence/Structure | MSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAGITHGMDELYK | |
Name of cargo | GFP | |
Assay | Fluorescent microscopy and Confocal microscopy | |
Enhancer | PBS,Oleic acid | |
Properties of enhancer | Oleic acid is a chemical enhancer | |
Concentration | 14uM of GFP mixed with 42µM of peptide | |
Incubation time | 1-60 minutes | |
Tissue permeability (value with units) | Best permiability is seen when GFP to peptide ratio is 1:3 and fluorescence microscopy results showed fluorescence in the hypo dermis | |
Tissue Sample | Backs of mice | |
Ex vivo/In vivo/In vitro | in vitro | |
STRUCTURE |
| |
SMILES | N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H] (CCCC[NH3])C(=O)N[C@@H](CCCC[NH3])C(=O) N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCC NC(=[NH2])N)C(=O)N[C@@H](CCC(=O)N) C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O) N[C@@H](CCCNC(=[NH2])N)C(=O)N [C@@H](CCCNC(=[NH2])N)C=O |